Therapeutic monoclonal antibodies in oncology.
Levene
Adam P
AP
Department of Cardiology, Leeds General Infirmary, Leeds LS1 3EX, UK.
Singh
Guminder
G
Palmieri
Carlo
C
D000617:Aminoglycosides / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D000068818:Cetuximab; D000079982:Gemtuzumab; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D000069283:Rituximab; D000068878:Trastuzumab
D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000068258:Bevacizumab; D000069283:Rituximab; D000079982:Gemtuzumab; D000068878:Trastuzumab; D000068818:Cetuximab